Bright Minds BiosciencesDRUG
13F holders, Q2 2024 (June 30)6holders −1
0new positions
1sold out
$1.05avg. 13F price*
At the end of Q2 2024, 6 institutions reported holding Bright Minds Biosciences Inc. (DRUG) in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holders were AdvisorShares Investments LLC ($190K), Jane Street Group, LLC ($12K) and National Bank of Canada ($5K).
- Company
- Bright Minds Biosciences Inc.
- CUSIP
- 10919W405
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $21K |
All 13F filers, Q1 2024 → Q2 2024: 4,954 shares bought and 20,789 shares sold, net −15,835 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| AdvisorShares Investments LLC | 0.03% | Add +2.8% | 180,992 | $190K |
| Jane Street Group, LLC | 0.00% | Reduce -20.7% | 10,937 | $12K |
| National Bank of Canada | 0.00% | No change | 5,000 | $5K |
| Royal Bank of Canada | 0.00% | Reduce -16.7% | 510 | $1K |
| Aspire Private Capital, LLC | 0.00% | No change | 100 | $108 |
| BlackRock Inc. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is DRUG's weight in each manager's 13F, not the share of Bright Minds Biosciences Inc. the manager owns.